Maspin, p53, p63, and Ki-67 in epithelial lesions of the tongue: From hyperplasia through dysplasia to carcinoma

Journal of Oral Pathology and Medicine

Volumn 38, Issue 3, 2009, Pages 314-320

  Vered, Marilena ^a,b   Allon, Irit ^a   Dayan, Dan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Carcinoma; Dyplasia; Maspin; P53; P63; Tongue

Indexed keywords

KI 67 ANTIGEN; MASPIN; PROTEIN P53; PROTEIN P63;

ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DYSPLASIA; HUMAN; HUMAN TISSUE; HYPERPLASIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TONGUE DISEASE; TONGUE DYSPLASIA; TONGUE HYPERPLASIA;

CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; HUMANS; HYPERPLASIA; KI-67 ANTIGEN; LEUKOPLAKIA, ORAL; SERPINS; TONGUE NEOPLASMS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 61349091856     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2008.00698.x     Document Type: Article

References (39)

1. Gale N, Pilch BZ, Sidransky D, et al. Epithelial precursor lesions. In : Barnes L, Eveson JW, Reichart P, Sidransky D, eds. World Health Organization Classification of Tumours. Pathology and genetics. Head and neck tumours. Lyon : IARC Press, 2005 177 9.
2. Penfold CN, Partridge M, Rojas R, Langdon JD. The role of angiogenesis in the spread of oral squamous cell carcinoma. Br J Oral Maxillofac Surg 1996 34 : 37 41.
3. Schoelch ML, Regezi JA, Dekker NP, et al. Cell cycle proteins and the development of oral squamous cell carcinoma. Oral Oncol 1999 35 : 333 42.
4. Bortoluzzi MC, Yurgel LS, Dekker NP, Jordan RC, Regezi JA. Assessment of p63 in oral squamous cell carcinoma and dysplasias. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004 98 : 698 704.
5. Chen Y-K, Hsue S-S, Lin L-M. Expression of p63 protein and mRNA in oral epithelial dysplasia. J Oral Pathol Med 2005 34 : 232 9.
6. Takeda T, Sugihara K, Hirayama Y, Hiramo M, Tanuma J-I, Emba I. Immunohistochemical evaluation of Ki-67, p63, CK19, and p53 expression in oral epithelial dysplasias. J Oral Pathol Med 2006 35 : 369 75.
7. Choi HR, Batsakis JG, Zhan F, Sturgis E, Luna MA, El-Naggar AK. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. Hum Pathol 2002 33 : 158 64.
8. Brennan M, Migliorati CA, Lockhart PB, et al. Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 103 (Suppl. 19.e1 12.
9. Scully C, Bagan JV. Recent advances in oral oncology. Oral Oncol 2007 43 : 107 15.
10. Zou Z, Anisowicz A, Hendrix MJ, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994 263 : 526 9.
11. Schneider SS, Schick C, Fish KE, et al. A serine proteinase inhibitor locus at 18q 21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci U S A 1995 92 : 3147 51.
12. Futscher BW, Oshiro MM, Wozniak RJ, et al. Role for DNA methylation in the control of cell type-specific maspin expression. Nat Genet 2002 31 : 175 9.
13. Lockett J, Yin S, Li X, Meng Y, Sheng S. Tumor suppressive maspin and epithelial homeostasis. J Cell Biochem 2006 97 : 651 60.
14. Nash JW, Bhardwaj A, Wen P, Frankel WL. Maspin is useful in the distinction between pancreatic adenocarcinoma from chronic pancreatitis: a tissue microarray based study. Appl Immunohistochem Mol Morphol 2007 15 : 59 63.
15. Friedrich MG, Toma MI, Petri S, et al. Expression of maspin in non-muscle invasive bladder carcinomas: correlation with tumor angiogenesis and prognosis. Eur Urol 2004 45 : 737 43.
16. Murai S, Maesawa C, Masuda T, Sugiyama T. Abberant maspin expression in human endometrial cancer. Cancer Sci 2006 97 : 883 8.
17. Bailey CM, Khalkhali-Ellis Z, Seftor EA, Hendrix MJ. Biological functions of maspin. J Cell Physiol 2006 209 : 617 24.
18. Kim S, Han J, Kim J, Park C. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression. Cancer Res 2004 64 : 6900 5.
19. Spiesbach K, Tannapfel A, Mossner J, Engeland K. TAp63k can substitute for p53 in inducing expression of the maspin tumor suppressor. Int J Cancer 2005 114 : 555 62.
20. Zou Z, Gao C, Nagaich AK, et al. p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem 2000 275 : 6051 4.
21. Domman FE, Futcher BW. Genetic and epigenetic regulation of Maspin gene expression in normal and tumor tissue. In : HENDRIX MJ ed. Maspin. Georgetown, TX : Eurekah.com/Landes Bioscience, 2002 68 93.
22. Strano S, Rossi M, Fontemaggi G, et al. From p63 to p53 across p73. FEBS Lett 2001 490 : 163 70.
23. Yang A, Kaghad M, Ang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating death-inducing, and dominant-negative activities. Mol Cell 1998 2 : 305 16.
24. Xia W, Lau Y-K, Hu MC-T, et al. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene 2000 19 : 2398 403.
25. Yasumatsu R, Nakashima T, Hirakawa N, et al. Maspin expression in stage I and stage II oral tongue squamous cell carcinoma. Head Neck 2001 23 : 962 6.
26. Cho JH, Kim H-S, Park C-S, et al. Maspin expression in early oral tongue cancer and its relation to expression of mutant-type p53 and vascular endothelial growth factor (VEGF). Oral Oncol 2006 43 : 272 7.
27. Johnson N, Franceschi S, Ferlay J, et al. Squamous cell carcinoma. In : BARNES L, EVESON JW, REICHART P, SIDRANSKY D eds. World Health Organization Classification of Tumours. Pathology and genetics. Head and neck tumours. Lyon : IARC Press, 2005 168 75.
28. Welsh JB, Sapinoso LM, Kern SG, et al. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc Natl Acad Sci USA, 2003 100 : 3410 5.
29. Vered M, Allon I, Buchner A, Dayan D. Stromal myofibroblasts and malignant transformation in a 4NQO rat tongue carcinogenesis model. Oral Oncol 2007 43 : 999 1006.
30. Abbas NF, Labib El-Sharkawy S, Abbas EA, Abdel Monen El-Shaer M. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 103 : 385 90.
31. Karabalut A, Reibel J, Therkildsen MH, Praetorius F, Nielsen HW, Dabelsteen E. Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol 1995 24 : 198 200.
32. Maass N, Teffner M, Rosel F, et al. Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast. J Pathol 2001 195 : 321 6.
33. Zhang M, Magit D, Sager R. Expression of maspin in prostate cells is regulated by a positive ets element and a negative hormonal responsive element site recognized by androgen receptor. Proc Natl Acad Sci USA 1997 94 : 5673 8.
34. Wang MC, Yang YM, Li XH, Dong F, Li Y. Maspin expression and its clinicopathological significance in tumorogenesis and progression of gastric cancer. World J Gastroenterol 2004 10 : 634 7.
35. Maesawa C, Ogasawara S, Yashima-Abo A, et al. Abberant maspin expression in gallbladder epithelium is associated with intestinal metaplasia in patients with cholelithiasis. J Clin Pathol 2006 59 : 328 30.
36. Maass N, Hojo T, Ueding M, et al. Expression of the tumor suppressor gene maspin in human pancreatic cancers. Clin Cancer Res 2001 7 : 812 7.
37. Cao D, Wilentz RE, Abbruzzese JL, Ho L, Maitra A. Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation. Int J Gastrointest Cancer 2005 36 : 39 46.
38. Nylander K, Dabelsteen E, Hall PA. The p53 molecule and its prognostic role in squamous cell carcinoma of the head and neck. J Oral Pathol Med 2000 29 : 413 25.
39. Nylander K, Vojtesec B, Nenutil R, et al. Differential expression of p63 isoforms in normal tissues and neoplastic cells. J Pathol 2002 198 : 417 27.